POSTER SESSION III Tuesday, March 1, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B PULMONARY PATHOLOGY 172 Expression of Markers of Cell Growth and Survival in Large Cell Neuroendocrine Lung Carcinoma (LCNC) of the Lung (1479) N Singhal, DS Zander, TC Allen, DE Killen, A Sienko, A Haque, R Barrios, PT Cagle - Baylor College of Medicine, Houston, TX; UTHSC-Houston Medical School, Houston, TX; UTHC-Tyler, Tyler, TX; The Methodist Hospital, Houston, TX 173 Comparison of DAX-1 and Androgen Receptor Expression in Small Cell Carcinoma and Carcinoid Tumors of the Lung (1477) A Sienko, TC Allen, DS Zander, N Singhal, D Killen, R Barrios, A Haque, PT Cagle - The Methodist Hospital, Houston, TX; University of Texas Health Center, Tyler, TX; University of Texas Health Science Center at Houston, Houston, TX; Baylor College of Medicine, Houston, TX 174 c-Met Receptor Tyrosine Kinase Is Expressed and Activated in Lung Carcinoma and Carcinoid Tumors (1445) AN Husain, T Krausz, M Tretiakova, PC Ma, R Salgia - University of Chicago, Chicago, IL 175 Expression of Anti-Oxidant Enzymes in Surgically Resected Small Cell Carcinoma (SCC) of the Lung (1480) N Singhal, DS Zander, TC Allen, DE Killen, A Sienko, A Haque, R Barrios, PT Cagle - Baylor College of Medicine, Houston, TX; UTHSC-Houston Medical School, Houston, TX; UTHC-Tyler, Tyler, TX; The Methodist Hospital, Houston, TX 176 EGFR Mutation Analysis in Atypical Adenomatous Hyperplasia of the Lung (1447) S Hussain, Q Pan, M Ladanyi, MF Zakowski Memorial Sloan-Kettering Cancer Center, New York, NY 177 Lung Adenocarcinoma with Mixed Subtypes, a Distinct Biologic Entity? (1497) L Zhu, AL Moreira, J Yim New York University Medical Center, New York, NY 178 Bronchioloalveolar Adenocarcinomas Versus Other Well Differentiated Primary Pulmonary Adenocarcinomas: Unique Immunohistochemical Phenotypes Identified by High Throughput Microarray (1473) CL Schiller, ZT Hammoud, KW Lannert, C Gatbunton, MJ Liptay, AG Nickolov, EB Merwitz, TA Hensing, EA Hahn, CD Sturgis - Evanston Northwestern Healthcare, Evanston, IL; Northwestern University Feinberg School of Medicine, Chicago, IL 179 Morphologic Features of Lung Adenocarcinomas in Relation to Responsiveness to Epidermal Growth Factor Receptor (EGFR) Inhibitors and EGFR Mutational Status (1493) MF Zakowski, S Hussain, W Pao, VA Miller, MG Kris - Memorial Sloan-Kettering Cancer Center, New York, NY 180 Analysis of EGFR Amplification in Pulmonary Adenocarcinomas by Chromogenic In Situ Hybridization (1448) S Hussain, W Pao, Q Pan, B Chen, M Ladanyi, MF Zakowski - Memorial Sloan-Kettering Cancer Center, New York, NY 181 Specific Involvement of EGFR Muataion in Adenocarcinoma with Features of Terminal Respiratory Unit (1491) Y Yatabe, T Kosaka, T Takahashi, T Mitsudomi - Aichi Cancer Center Hospital, Nagoya, Japan; Aichi Cancer Center Research Institute, Nagoya, Japan 182 Intensity of Estrogen Receptor beta Expression Predicts Prognosis in Early Stage Pulmonary Adenocarcinoma (1423) TC Allen, DS Zander, A Sienko, N Singhal, DE Killen, A Haque, PT Cagle - University of Texas Health Center at Tyler, Tyler, TX; University of Texas Health Science Center at Houston Medical School, Houston, TX; The Methodist Hospital, Houston, TX; Baylor College of Medicine, Houston, TX 183 MUC4 Expression in High-Throughput Tissue Microarray of 343 Non-Small Cell Lung Carcinomas with Long-Term Follow-Up: Relationship to Survival (1455) KY Kwon, DS Zander, DE Killen, A Sienko, R Barrios, A Haque, PT Cagle - Baylor College of Medicine, UTHSC-Houston Medical School, The Methodist Hospital, Houston, TX 184 MUC4 Expression Differentiates Diffuse Malignant Mesothelioma from Non-Small Cell Carcinoma of the Lung: A High-Density Tissue Microarray Study (1458) R Laucirica, KY Kwon, DS Zander, DE Killen, N Singhal, A Haque, A Sienko, R Barrios, TC Allen, PT Cagle - Baylor College of Medicine, UTHSC-Houston Medical Center, The Methodist Hospital, Houston, TX; UTHC-Tyler, Tyler, TX 185 LOH Mutations in Pleural Mesotheliomas, Metastatic Pulmonary Adenocarcinomas, and Benign Pleural Mesothelium: Preliminary Microsatellite Marker Panel for a Rapid Molecular Assay (1436) T Friedman, NS Goldstein, E Odish William Beaumont Hospital, Royal Oak, MI 186 FRAT 2 Expression in Malignant Mesotheliomas: A Tissue Microarray and Immunohistochemical Comparison with Other Lung Malignancies (1427) R Barrios, N Singhal, DE Killen, DS Zander, A Sienko, A Haque, PT Cagle - The Methodist Hospital, Baylor College of Medicine, UTHSC-Houston Medical School, Houston, TX 187 p63 Is a Useful Marker in Distinguishing Pleural Malignant Mesothelioma (PMM) from Pulmonary Squamous Cell Carcinoma (SCC) Involving Pleura (1484) MA Vasef, K Sheibani University of Iowa Hospitals and Clinics, Iowa City, IA; University of Southern California, Los Angeles, CA 188 CD138 Is Not a Helpful Marker in Distinguishing Spindle Cell Adenocarcinoma (SCA) from Malignant Mesothelioma (MM): A Paraffin Immunohistochemical Study (1485) MA Vasef, S Sheibani, K Sheibani - University of Iowa Hospitals and Clinics, Iowa City, IA; University of California Irvine, Irvine, CA; University of Southern California, Los Angeles, CA 189 D2-40 Is a Novel New Marker of Malignant Mesothelioma (MM): Tissue Microarray Study of 45 MM Versus 409 Lung Carcinomas and Primary Non-Mesothelial Neoplasms of the Pleura and Chest Wall (1476) A Sienko, DS Zander, D Killen, N Singhal, R Barrios, A Haque, PT Cagle - The Methodist Hospital, Houston, TX; University of Houston Health Science Center School of Medicine, Houston, TX; Baylor College of Medicine, Houston, TX 190 Expression and Activation of c-Met Receptor Tyrosine Kinase in Malignant Mesothelioma (1446) AN Husain, T Krausz, M Tretiakova, R Kratzke, PC Ma, R Salgia - University of Chicago, Chicago, IL; University of Minnesota, Minneapolis-St.Paul, MN 191 Gene Silencing of PCNA in Mesothelioma Cell Lines Causes Deregulation of Other Genes (1453) H Kothmaier, S Petzmann, I Halbwedl, HH Popper - Institute of Pathology, Medical University, Graz, Austria 192 Immunophenotypic Profile of SV40-Induced Diffuse Malignant Mesothelioma (DMM) in Hamsters: Similarities with Human DMM (1488) RA Vilchez, DE Killen, JS Butel, DS Zander, HH Popper, PT Cagle - Baylor College of Medicine, Houston, TX; UTHSC-Houston Medical School, Houston, TX; University of Graz, Graz, Austria; The Methodist Hospital, Houston, TX 193 SV40 and Malignant Mesothelioma: A Molecular and Immunohistochemical Study of 83 Cases from USA and Two Different Regions of Turkey (1496) EH Zeren, M Ergin, D Gumurdulu, F Demirag, P Cagle - Cukurova University, Faculty of Medicine, Adana, Turkey; Ataturk Chest Hospital, Ankara, Turkey; The Methodist Hospital, Houston, TX 194 Clinicopathological Study of 23 Malignant Mesotheliomas Showing Osseous and Cartilaginous (Heterologous) Differentiation (1438) AR Gibbs, FB Galateau-Salle, RL Attanoos - Cardiff and Vale NHS Trust, Penarth, South Glamorgan, United Kingdom; Cote de Nacre Hospital, Caen, Normandie, France; Cardiff and Vale NHS Trust, Penarth, South Glamorgan, United Kingdom